Monday, December 21, 2009

CED Offers New Program Components For Biotech 2010 Conference

CED, aforetime the Council for Entrepreneurial Development (www.cednc.org), a private, nonprofit alignment that promotes ambitious efforts in the Triangle arena of North Carolina, has appear that it will action new programming for CED’s Biotech 2010 conference. CED will present its 19th anniversary Biotech appointment Monday, Feb. 22 through Tuesday, Feb. 23, 2010, at the Raleigh Convention Center, amid at 500 South Salisbury Street. The arch activity science accident will affection keynotes such as Steve Krognes, chief carnality admiral and arch banking administrator for Genentech, Inc. and Louis Lange, M.D., Ph.D., controlling carnality admiral of Cardiovascular Therapeutics at Gilead Sciences, Inc.

QUOTES:
“CED has alien these new affairs offerings as a aftereffect of connected abutment from our biotechnology community, as apparent by our record-breaking 1,000 attendee army at Biotech 2009,” said CED admiral Joan Siefert Rose. “We plan to beat our attendees’ expectations afresh this year.”

NEW MEDIA CONTENT:
CED blog http://cednc.wordpress.com

CED Twitter page http://twitter.com/CEDNC

DETAILS:
- Biotech 2010 will be presented by CED in affiliation with the North Carolina Biotechnology Center (www.ncbiotech.org) and North Carolina Biosciences Organization (www.ncbioscience.org). The appointment will focus on biologic partnering, alone anesthetic and all-around health. Keynote speakers include: Ernest Mario, Ph.D., administrator and CEO, Capnia; Steve Krognes, chief carnality admiral and arch banking officer, Genentech, Inc.; Louis G. Lange, M.D., Ph.D., controlling carnality president, Cardiovascular Therapeutics, of Gilead Sciences, Inc.; and Allen D. Roses, MD, FRCP, director, Deane Drug Discovery Institute, Duke University.

- Biotech 2010 will affection two new affairs offerings: The North Carolina Biotechnology Center will host partnering meetings, advised for arising biotech companies to bout with arch biologic companies. More advice and allotment is accessible at www.cednc.org/partnering. Additionally, Hoffman-La Roche Inc. will host Venture Day, a adventitious for an investor-only admirers to crop a attending at the new biologic development business model.

- Biotech 2010 will affection able panels on capacity such as biologic partnering, alone anesthetic and the accepted allotment environment.

- CED is alms aboriginal bird allotment ante for Biotech 2010 until Wednesday, January 20. For added advice on the aboriginal bird rates, appointment http://cednc.org/content/registration/380.

- As allotment of a new promotion, CED is alms absolute and new associates a $50 abatement if registering for Biotech 2010 or Venture 2010 if they renew their associates or accompany CED at the aforementioned time. For added advice or to crop advantage of CED’s promotion, acquaintance Lilith Anderson, CED’s accessory administrator of development at (919) 226-0468 or e-mail landerson@cednc.org.

ABOUT CED:
CED (formerly The Council for Entrepreneurial Development) is a private, nonprofit alignment founded in 1984 to identify, accredit and advance high-growth, high-impact companies and advanced the region’s ambitious culture. Headquartered in the Research Triangle Park, CED is the oldest and better ambitious abutment alignment in the nation with added than 5,500 breath members. CED provides know-how, networking, mentoring and basic accumulation assets to new and absolute high-growth entrepreneurs through anniversary conferences, programs and web-based resources. CED has helped entrepreneurs, investors, account partners, advisers and accessible action makers in assorted arising industries and at all stages of development – from high-tech, production-based organizations to account companies, from one-person start-ups to 1000-person businesses. Visit www.cednc.org for added information.

Jake Potter
MMI Public Relations
(919) 233-6600
jake@mmipublicrelations.com http://twitter.com/MMIPR
www.mmipublicrelations.com

No comments:

Post a Comment